Scientific Information Database (SID) - Trusted Source for Research and Academic Resources

video

Scientific Information Database (SID) - Trusted Source for Research and Academic Resources

sound

Scientific Information Database (SID) - Trusted Source for Research and Academic Resources

Persian Version

Scientific Information Database (SID) - Trusted Source for Research and Academic Resources

View:

355
Scientific Information Database (SID) - Trusted Source for Research and Academic Resources

Download:

147
Scientific Information Database (SID) - Trusted Source for Research and Academic Resources

Cites:

Information Journal Paper

Title

DESIGN OF SMALL MOLECULES WITH HIV FUSION INHIBITORY PROPERTY BASED ON GP41 INTERACTION ASSAY

Pages

  78-86

Abstract

 Background: Gp41 of HIV (Human Immunodeficiency Virus) is a protein that mediates fusion between viral and cellular membranes. The agent, T-20, which has been approved for HIV inhibition, can restrain Gp41 function in the fusion process; nevertheless, it has disadvantages like instability, high cost of production and injection form to be delivered twice a day.Methods: Several molecules like NB-2 and NB-64 have been discovered that can inhibit HIV infection. These molecules were used as template compounds to design and develop more effective small molecules functioning as HIV-1 fusion inhibitors targeting Gp41. The process included in silico docking protocols using HEX and ArgusLab applications. A multisource database was created, after choosing the best molecules; they were tested in vitro for inhibitory activity by HIV-1 single-cycle model, transfected in HEK cells (293T).Results: Computational analysis and experimental data were combined to explore molecular properties and the most potent ones were found, with the best suitable criteria for interaction with Gp41. Several examples (DAA-6, DAA-9 and DAA-12) could inhibit infection in vitro as effective as NB-2, NB-64.Conclusion: Since disadvantages of available fusion inhibitor (T-20), it seems necessary to find similar molecules to be approved and have small size pro-viding suitable bioactivity profile. The molecules explored in this study can be good candidates for further investigations to be used as oral HIV fusion inhibitors in the future.

Cites

  • No record.

    • References

    Cite

    APA: Copy

    SARDARI, SOROUSH, AZADMANESH, KAYHAN, MAHBOUDI, FEREIDOUN, DAVOOD, ASGHAR, VAHABPOUR, RUHOLLAH, ZABIHOLLAHI, REZVAN, & GOMARI, HOSNA. (2013). DESIGN OF SMALL MOLECULES WITH HIV FUSION INHIBITORY PROPERTY BASED ON GP41 INTERACTION ASSAY. AVICENNA JOURNAL OF MEDICAL BIOTECHNOLOGY (AJMB), 5(2 (17)), 78-86. SID. https://sid.ir/paper/313812/en

    Vancouver: Copy

    SARDARI SOROUSH, AZADMANESH KAYHAN, MAHBOUDI FEREIDOUN, DAVOOD ASGHAR, VAHABPOUR RUHOLLAH, ZABIHOLLAHI REZVAN, GOMARI HOSNA. DESIGN OF SMALL MOLECULES WITH HIV FUSION INHIBITORY PROPERTY BASED ON GP41 INTERACTION ASSAY. AVICENNA JOURNAL OF MEDICAL BIOTECHNOLOGY (AJMB)[Internet]. 2013;5(2 (17)):78-86. Available from: https://sid.ir/paper/313812/en

    IEEE: Copy

    SOROUSH SARDARI, KAYHAN AZADMANESH, FEREIDOUN MAHBOUDI, ASGHAR DAVOOD, RUHOLLAH VAHABPOUR, REZVAN ZABIHOLLAHI, and HOSNA GOMARI, “DESIGN OF SMALL MOLECULES WITH HIV FUSION INHIBITORY PROPERTY BASED ON GP41 INTERACTION ASSAY,” AVICENNA JOURNAL OF MEDICAL BIOTECHNOLOGY (AJMB), vol. 5, no. 2 (17), pp. 78–86, 2013, [Online]. Available: https://sid.ir/paper/313812/en

    Related Journal Papers

  • No record.

    • Related Seminar Papers

  • No record.

    • Related Plans

  • No record.

    • Recommended Workshops






    Move to top